LEADER 03817namaa2200961uu 4500
001 doab98016
003 oapen
005 20230307
006 m o d
007 cr|mn|---annan
008 230307s2023 xx |||||o ||| 0|eng d
020 |a 9783036565132 
020 |a 9783036565149 
020 |a books978-3-0365-6514-9 
024 7 |a 10.3390/books978-3-0365-6514-9  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PS  |2 bicssc 
720 1 |a Schuurmans, Macé M.  |4 edt 
720 1 |a Hage, René  |4 edt 
720 1 |a Hage, René  |4 oth 
720 1 |a Schuurmans, Macé M.  |4 oth 
245 0 0 |a Solid Organ Transplantation in the Era of COVID-19 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 online resource (128 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19), posing a new challenge to the medical care of solid organ transplant (SOT) recipients. Due to the relatively small number of studies in SOT recipients suffering from COVID-19, the natural course of the SARS-CoV-2 infection, optimal treatment strategies including modification of immunosuppressive therapy and the prognosis in COVID-19 in these patients is incompletely understood. The current Special Issue aimed to fill some of the knowledge gaps and highlight some recent advances in the management of SOT patients during the pandemic. The call for manuscripts had been addressed to healthcare professionals involved in SOT patient care. We welcomed comprehensive reviews, original studies, interesting case series or case reports and commentaries relating to this topic. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Biology, life sciences  |2 bicssc 
650 7 |a Research & information: general  |2 bicssc 
653 |a breakthrough infections 
653 |a chronic lung allograft dysfunction 
653 |a CLAD hypothesis 
653 |a community-acquired respiratory viral infection 
653 |a coronavirus 
653 |a Coronavirus 
653 |a corticosteroids 
653 |a COVID-19 
653 |a cyclosporine 
653 |a cytokine storm 
653 |a cytokine storm syndrome 
653 |a dexamethasone 
653 |a fibrosis 
653 |a FK506 
653 |a hemodialysis 
653 |a hyperinflammation 
653 |a hypothesis 
653 |a immunocompromised 
653 |a immunosuppression 
653 |a infection 
653 |a inflammation 
653 |a kidney 
653 |a lung transplant recipients 
653 |a lung transplantation 
653 |a Lung Transplantation 
653 |a mycophenolate mofetil 
653 |a myocarditis 
653 |a n/a 
653 |a norovirus 
653 |a pandemic 
653 |a PCR 
653 |a pediatric heart transplantation 
653 |a phenotype hypothesis 
653 |a remdesivir 
653 |a SARS-CoV-2 
653 |a solid-organ transplant 
653 |a survival 
653 |a tacrolimus 
653 |a transplant 
653 |a transplant recipients 
653 |a transplantation 
653 |a treatment 
653 |a unvaccinated 
653 |a viral infection 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/98016  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/6743  |7 0  |z Open Access: DOAB, download the publication